Agaath Hedina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Agaath Hedina has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Vijaya Anand
4 shared publicationsJuveriyah Kausar
3 shared publicationsPushpa P
3 shared publicationsAlina Buture
Mater Misericordiae University Hospital Dublin Ireland
2 shared publicationsDurai Muthumani
2 shared publicationsEsther Tomkins
Beaumont Hospital Dublin Ireland
2 shared publications
Latest Publications
- Open Access
- 16 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04625
Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future. Patients with a background of Raynaud's phenomenon may experience worsening of their symptoms if started on these treatments.
- 16 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04625
Open AccessRaynaud's phenomenon secondary to erenumab in a patient with chronic migraine
Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future. Patients with a background of Raynaud's phenomenon may experience worsening of their symptoms if started on these treatments.
- 30 May 2021
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 12 (4) , 649-657
Chemotherapeutic Resistance Genes of Breast Cancer Patients – An Overview
Purpose: Cancer is the leading challenge to human health since the dawn of early Egyptian manuscripts, where they found tumour from fossils in the modernized twentieth century. Increasing rate of incidence and death from cancer in the past few years is thought provoking. Among all type of cancers, breast cancer is very common among women and diverse in character. Drug resistance is the challenging aspect for traditional chemotherapy. Methods: Data was collected from online platform without any time restriction. After screening and evaluation, 66 articles were considered for this study. This review is a summarized collection of information from published studies on human genes associated with drug resistance in breast cancer treatment. Results: Analysis of these findings highlights the importance of MAP kinase and ABC gene families in creating resistance barriers. Genes involved in cell cycle alteration, apoptosis, and hippo pathway were also linked with drug resistance particularly in breast cancer. Conclusion: The exact mechanism of chemotherapy resistance is still unresolved and unexplained the drug resistance seen in breast cancer patients were multifactorial. Drug induced up regulation or down regulation of genes contributes unusual protein expression and ultimately leads to resistance. The ultimate focus of this review is to identify the genes having pivotal role in chemotherapy resistance in breast cancer.
- 30 May 2021
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 12 (4) , 649-657
Chemotherapeutic Resistance Genes of Breast Cancer Patients – An Overview
Purpose: Cancer is the leading challenge to human health since the dawn of early Egyptian manuscripts, where they found tumour from fossils in the modernized twentieth century. Increasing rate of incidence and death from cancer in the past few years is thought provoking. Among all type of cancers, breast cancer is very common among women and diverse in character. Drug resistance is the challenging aspect for traditional chemotherapy. Methods: Data was collected from online platform without any time restriction. After screening and evaluation, 66 articles were considered for this study. This review is a summarized collection of information from published studies on human genes associated with drug resistance in breast cancer treatment. Results: Analysis of these findings highlights the importance of MAP kinase and ABC gene families in creating resistance barriers. Genes involved in cell cycle alteration, apoptosis, and hippo pathway were also linked with drug resistance particularly in breast cancer. Conclusion: The exact mechanism of chemotherapy resistance is still unresolved and unexplained the drug resistance seen in breast cancer patients were multifactorial. Drug induced up regulation or down regulation of genes contributes unusual protein expression and ultimately leads to resistance. The ultimate focus of this review is to identify the genes having pivotal role in chemotherapy resistance in breast cancer.
- Open Access
- 6 April 2021
- Published by Wiley
Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
The case of a 45 year old female with chronic migraine undergoing treatment with erenumab 70 mg subcutaneous injection who developed Raynaud’s phenomenon (RP) as a side effect with relevant clinical implications two weeks after the second dose of erenumab injection.
- 6 April 2021
- Published by Wiley
Open AccessRaynaud's phenomenon secondary to erenumab in a patient with chronic migraine
The case of a 45 year old female with chronic migraine undergoing treatment with erenumab 70 mg subcutaneous injection who developed Raynaud’s phenomenon (RP) as a side effect with relevant clinical implications two weeks after the second dose of erenumab injection.
- Open Access
- 1 January 2017
- Published by Medknow in Indian Journal Of Ophthalmology
- Vol. 65 (11) , 1087-1092
Mitochondrial genetics and therapeutic overview of Leber's hereditary optic neuropathy
Leber's hereditary optic neuropathy (LHON) is a common inherited mitochondrial disorder that is characterized by the degeneration of the optic nerves, leading to vision loss. The major mutations in the mitochondrial genes ND1, ND4, and ND6 of LHON subjects are found to increase the oxidative stress experienced by the optic nerve cell, thereby leading to nerve cell damage. Accurate treatments are not available and drugs that are commercially available like Idebenone, EPI-743, and Bendavia with their antioxidant role help in reducing the oxidative stress experienced by the cell thereby preventing the progression of the disease. Genetic counseling plays an effective role in making the family members aware of the inheritance pattern of the disease. Gene therapy is an alternative for curing the disease but is still under study. This review focuses on the role of mitochondrial genes in causing LHON and therapeutics available for treating the disease. A systematic search has been adopted in various databases using the keywords “LHON,” “mitochondria,” “ND1,” “ND4,” “ND6,” and “therapy” and the following review on mitochondrial genetics and therapeutics of LHON has been developed with obtained articles from 1988 to 2017.
- 1 January 2017
- Published by Medknow in Indian Journal Of Ophthalmology
- Vol. 65 (11) , 1087-1092
Open AccessMitochondrial genetics and therapeutic overview of Leber's hereditary optic neuropathy
Leber's hereditary optic neuropathy (LHON) is a common inherited mitochondrial disorder that is characterized by the degeneration of the optic nerves, leading to vision loss. The major mutations in the mitochondrial genes ND1, ND4, and ND6 of LHON subjects are found to increase the oxidative stress experienced by the optic nerve cell, thereby leading to nerve cell damage. Accurate treatments are not available and drugs that are commercially available like Idebenone, EPI-743, and Bendavia with their antioxidant role help in reducing the oxidative stress experienced by the cell thereby preventing the progression of the disease. Genetic counseling plays an effective role in making the family members aware of the inheritance pattern of the disease. Gene therapy is an alternative for curing the disease but is still under study. This review focuses on the role of mitochondrial genes in causing LHON and therapeutics available for treating the disease. A systematic search has been adopted in various databases using the keywords “LHON,” “mitochondria,” “ND1,” “ND4,” “ND6,” and “therapy” and the following review on mitochondrial genetics and therapeutics of LHON has been developed with obtained articles from 1988 to 2017.
- Open Access
- 1 July 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 8 (4) , 310-313
Review of the phytochemical and pharmacological activities of Euphorbia hirta Linn.
- 1 July 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 8 (4) , 310-313
Open AccessReview of the phytochemical and pharmacological activities of Euphorbia hirta Linn.
- Open Access
- 1 July 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 8 (4) , 314-320
Phytopharmacological overview of Psidium guajava Linn.
- 1 July 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 8 (4) , 314-320
Open AccessPhytopharmacological overview of Psidium guajava Linn.
- Open Access
- 1 July 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 8 (4) , 307-309
Phytopharmacological overview of Terminalia chebula Retz
- 1 July 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 8 (4) , 307-309
Open AccessPhytopharmacological overview of Terminalia chebula Retz
- Open Access
- 1 June 2016
- Published by SynthesisHub Advance Scientific Research in Systematic Reviews in Pharmacy
- Vol. 7 (1) , 24-29
Cinnamomum zeylanicum Linn. The spice with multi potential
- 1 June 2016
- Published by SynthesisHub Advance Scientific Research in Systematic Reviews in Pharmacy
- Vol. 7 (1) , 24-29
Open AccessCinnamomum zeylanicum Linn. The spice with multi potential
- Open Access
- 1 June 2016
- Published by SynthesisHub Advance Scientific Research in Systematic Reviews in Pharmacy
- Vol. 7 (1) , 30-34
Phytopharmacological activities of Euphorbia thymifolia Linn.
- 1 June 2016
- Published by SynthesisHub Advance Scientific Research in Systematic Reviews in Pharmacy
- Vol. 7 (1) , 30-34
Open AccessPhytopharmacological activities of Euphorbia thymifolia Linn.
- 1 January 2016
- Published by Medknow in Clinical and Translational Degenerative Diseases
- Vol. 1 (2) , 77
Remarkable achievements in multiple sclerosis
Multiple sclerosis as a demyelinating disease is characterized by divergent clinical symptoms in the central nervous system. To date, its etiology is still indefinite. Out of the human leukocyte antigen (HLA) region, there are different aspects contributing to multiple sclerosis. Some genome-wide association studies have shown several non-HLA genes play a major role in multiple sclerosis. Additionally, a few single nucleotide polymorphisms in non-HLA genes are likely to be predisposing markers for multiple sclerosis, including rs6897932 in IL7RA, and rs2104286, rs12044852 in IL2RA and CD58 genes, respectively. However, the exact region in the mitochondria is still now indefinite. Given that relevant studies are mostly from Europe, further investigation in different cohorts throughout the world is warranted.
- 1 January 2016
- Published by Medknow in Clinical and Translational Degenerative Diseases
- Vol. 1 (2) , 77
Remarkable achievements in multiple sclerosis
Multiple sclerosis as a demyelinating disease is characterized by divergent clinical symptoms in the central nervous system. To date, its etiology is still indefinite. Out of the human leukocyte antigen (HLA) region, there are different aspects contributing to multiple sclerosis. Some genome-wide association studies have shown several non-HLA genes play a major role in multiple sclerosis. Additionally, a few single nucleotide polymorphisms in non-HLA genes are likely to be predisposing markers for multiple sclerosis, including rs6897932 in IL7RA, and rs2104286, rs12044852 in IL2RA and CD58 genes, respectively. However, the exact region in the mitochondria is still now indefinite. Given that relevant studies are mostly from Europe, further investigation in different cohorts throughout the world is warranted.